Glywohn VM 2mg/500mg/0.3mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glywohn VM 2mg/500mg/0.3mg Tablet
Diabetic patients (adults) utilize the triple-combination anti-diabetic medication, Glywohn VM 2mg/500mg/0.3mg Tablet, to manage type 2 diabetes mellitus. This formulation helps regulate blood glucose. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar monitoring. Continuous use is crucial; premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease necessitates physician consultation before initiating treatment. Pregnant or breastfeeding individuals require medical advice before use. Regular blood sugar checks are mandatory, along with potential blood tests to monitor blood cell counts and liver function.
Uses of Glywohn VM 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glywohn VM 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glywohn VM 2mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Glywohn VM 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glywohn VM 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glywohn VM 2mg/500mg/0.3mg Tablet on an empty stomach.
How Glywohn VM 2mg/500mg/0.3mg Tablet works:
Each Glywohn VM tablet (2mg/500mg/0.3mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glywohn VM 2mg/500mg/0.3mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glywohn VM 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Glywohn VM 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glywohn VM 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Glywohn VM 2mg/500mg/0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver disease, Glywohn VM 2mg/500mg/0.3mg tablets are typically initiated at a reduced dosage; however, their use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Glywohn VM 2mg/500mg/0.3mg Tablet :
Should you forget to take a Glywohn VM 2mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glywohn VM 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently